SELB Selecta Biosciences Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.

$1.34  +0.01 (0.75%)
As of 06/27/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/22/2016
Outstanding shares:  151,809,416
Average volume:  3,374,067
Market cap:   $201,906,523
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZB1WS8
Valuation   (See tab for details)
PE ratio:   7.29
PB ratio:   2.97
PS ratio:   2.58
Return on equity:   49.65%
Net income %:   35.44%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy